AG-67650, a bi-specific fusion protein for the treatment of wet age-related macular degeneration

Wheeler Larry A.; Wu Artemis; Chang Ben; Tan Nguyen; Cherukury Madhu

首页> 外文期刊>Investigative ophthalmology & visual science >AG-67650, a bi-specific fusion protein for the treatment of wet age-related macular degeneration

【24h】

AG-67650, a bi-specific fusion protein for the treatment of wet age-related macular degeneration

机译：AG-67650，一种用于治疗湿年龄相关性黄斑变性的双特异性融合蛋白

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2019年第9期|共2页
作者
Wheeler Larry A.; Wu Artemis; Chang Ben; Tan Nguyen; Cherukury Madhu;
展开▼
作者单位

Zeteo Drug Discovery LLC Irvine CA USA;

Allgenesis Biotherapeut Inc Taipei Taiwan;

Allgenesis Biotherapeut Inc Taipei Taiwan;

Allgenesis Biotherapeut Inc Taipei Taiwan;

Allgenesis Biotherapeut Inc Taipei Taiwan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. AG-67650, a bi-specific fusion protein for the treatment of wet age-related macular degeneration [J] . Wheeler Larry A., Wu Artemis, Chang Ben, Investigative ophthalmology & visual science . 2019,第9期

机译：AG-67650，一种用于治疗湿年龄相关性黄斑变性的双特异性融合蛋白
2. Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with antivascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761) [J] . Gillies Mark C., Daien Vincent, Nguyen Vuong, Ophthalmology . 2017,第3期

机译：Re：年龄相关的黄斑变性治疗试验（CATT）研究组，等人类的比较：抗病毒内皮生长因子治疗新生血管年龄相关黄斑变性的五年成果：年龄相关黄斑变性治疗试验的比较（ 2016年眼科学; 123：1751-1761）
3. Faricimab Anti-Ang-2/anti-VEGF-A bispecific antibody Treatment of diabetic macular edema Treatment of wet age-related macular degeneration [J] . Drugs of the Future . 2020,第7期

机译：FariCIMAB抗Ang-2 /抗VEGF-A双特异性抗体治疗糖尿病性黄斑水肿治疗湿式年龄相关性黄斑变性
4. Knowledge discovery in ophthalmology: analysis of wet form of Age-related Macular Degeneration treatment outcomes [C] . Magdalena Ulinska, Emanuel Tataj, Jan Mulawka, Conference on photonics applications in astronomy, communications, industry, and high-energy physics experiments . 2009

机译：眼科知识发现：与年龄相关的黄斑变性的湿润形式治疗结果分析
5. Characterizing response patterns to ranibizumab therapy in patients with wet age-related macular degeneration: A latent class growth analysis [D] . Sun, Diana 2015

机译：潮湿年龄相关性黄斑变性患者的ranibizumab治疗的表征反应模式：潜在的增长分析
6. Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration Corrigendum [O] . 2017

机译：湿性年龄相关性黄斑变性患者的黄斑形态和对兰尼单抗治疗的反应更正
7. Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration Corrigendum [O] . Nikolaos Dervenis, Saad Younis 2016

机译：潮湿年龄相关性黄斑变性患者Ranibizumab治疗的黄斑形态和反应逆变

AG-67650, a bi-specific fusion protein for the treatment of wet age-related macular degeneration

著录项

相似文献

相关主题

期刊订阅